Search research articles
Contact Us
Filters
Showing results (191-200 of 683) with videos related to
Page
of 69
Sort By:
Genetics
|
April 15, 2004
Multiple loci and epistases control genetic variation for seed dormancy in weedy rice (Oryza sativa)
Xing-You Gu, Shahryar F Kianian, Michael E Foley
Genetics
|
November 8, 2005
Dormancy genes from weedy rice respond divergently to seed development environments
Xing-You Gu, Shahryar F Kianian, Michael E Foley
Irish Medical Journal
|
October 31, 2009
Cerebral palsy following neonatal hypoxic seizures in singleton term infants: the influence of parity
R Mahony, F Enright, C O'Herlihy, et al.
Heredity
|
September 29, 2005
Isolation of three dormancy QTLs as Mendelian factors in rice
X Y Gu, S F Kianian, M E Foley
Experimental Cell Research
|
November 1, 1972
Human leukemic cells. Fractionation and characterization of ribonucleic acids
U C Wulff, L S Desai, G E Foley
BMC Medical Education
|
May 23, 2024
Investigating racial/ethnic differences in procedure experience in obstetrics & gynecology trainees at a single academic institution: a retrospective cohort study
Patricia GiglioAyers, Christine E Foley, Beth Cronin, et al.
Vascular Health and Risk Management
|
March 19, 2011
Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies
Anja Schweizer, Sylvie Dejager, James E Foley, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
March 22, 2007
Vildagliptin in drug-naïve patients with type 2 diabetes: a 24-week, double-blind, randomized, placebo-controlled, multiple-dose study
S Dejager, S Razac, J E Foley, et al.
Genetica
|
December 22, 2004
A set of three genes regulates photoperiodic responses of flowering in rice (Oryza sativa)
Xing-You Gu, Michael E Foley, Zong-Xiang Chen
Vascular Health and Risk Management
|
November 28, 2014
Changes in body weight after 24 weeks of vildagliptin therapy as a function of fasting glucose levels in patients with type 2 diabetes
Matthias Blüher, Anja Schweizer, Giovanni Bader, et al.
Page
of 69
Search research articles
Search
Showing results (191-200 of 683) with videos related to
Sort By:
Page
of 69
Genetics
|
April 15, 2004
Multiple loci and epistases control genetic variation for seed dormancy in weedy rice (Oryza sativa)
Xing-You Gu, Shahryar F Kianian, Michael E Foley
Genetics
|
November 8, 2005
Dormancy genes from weedy rice respond divergently to seed development environments
Xing-You Gu, Shahryar F Kianian, Michael E Foley
Irish Medical Journal
|
October 31, 2009
Cerebral palsy following neonatal hypoxic seizures in singleton term infants: the influence of parity
R Mahony, F Enright, C O'Herlihy, et al.
Heredity
|
September 29, 2005
Isolation of three dormancy QTLs as Mendelian factors in rice
X Y Gu, S F Kianian, M E Foley
Experimental Cell Research
|
November 1, 1972
Human leukemic cells. Fractionation and characterization of ribonucleic acids
U C Wulff, L S Desai, G E Foley
BMC Medical Education
|
May 23, 2024
Investigating racial/ethnic differences in procedure experience in obstetrics & gynecology trainees at a single academic institution: a retrospective cohort study
Patricia GiglioAyers, Christine E Foley, Beth Cronin, et al.
Vascular Health and Risk Management
|
March 19, 2011
Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies
Anja Schweizer, Sylvie Dejager, James E Foley, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
March 22, 2007
Vildagliptin in drug-naïve patients with type 2 diabetes: a 24-week, double-blind, randomized, placebo-controlled, multiple-dose study
S Dejager, S Razac, J E Foley, et al.
Genetica
|
December 22, 2004
A set of three genes regulates photoperiodic responses of flowering in rice (Oryza sativa)
Xing-You Gu, Michael E Foley, Zong-Xiang Chen
Vascular Health and Risk Management
|
November 28, 2014
Changes in body weight after 24 weeks of vildagliptin therapy as a function of fasting glucose levels in patients with type 2 diabetes
Matthias Blüher, Anja Schweizer, Giovanni Bader, et al.
Page
of 69